Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis

[1]  M. Cutolo,et al.  Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. , 2022, Microvascular research.

[2]  F. Cipollone,et al.  Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis , 2021, Cells.

[3]  M. Cutolo,et al.  Detection of microvascular changes in systemic sclerosis and other rheumatic diseases , 2021, Nature Reviews Rheumatology.

[4]  E. Crouser,et al.  Challenges of Sarcoidosis and Its Management. , 2021, The New England journal of medicine.

[5]  J. Meng,et al.  Associations between sarcoidosis, autoimmune diseases, and autoantibodies: a single-center retrospective study in China , 2021, Clinical and Experimental Medicine.

[6]  M. Cutolo,et al.  Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings , 2021, Arthritis Research & Therapy.

[7]  A. Herrick,et al.  Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus , 2021, Rheumatology International.

[8]  M. Cutolo,et al.  Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update , 2021, European journal of clinical investigation.

[9]  M. Cutolo,et al.  Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. , 2021, Autoimmunity reviews.

[10]  M. Veltkamp,et al.  Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects , 2020, Frontiers in Immunology.

[11]  R. Blankstein,et al.  Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline , 2020, American journal of respiratory and critical care medicine.

[12]  A. Iagnocco,et al.  Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. , 2020, Autoimmunity reviews.

[13]  L. Churilov,et al.  Sarcoidosis as an Autoimmune Disease , 2020, Frontiers in Immunology.

[14]  M. Cutolo,et al.  Might Nailfold Capillaroscopy Be a “Proxy” for Lung Involvement in Connective Tissue Diseases? , 2019, The Journal of Rheumatology.

[15]  M. Cutolo,et al.  Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity. , 2019, Microvascular research.

[16]  V. Bernardino,et al.  Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic , 2019, Rheumatology International.

[17]  J. Grunewald,et al.  Sarcoidosis , 2019, Nature Reviews Disease Primers.

[18]  T. Lv,et al.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis. , 2019, Translational lung cancer research.

[19]  U. Müller-Ladner,et al.  SAT0296 FAST TRACK ALGORITHM: HOW TO DIFFERENTIATE A SCLERODERMA PATTERN FROM A NON-SCLERODERMA PATTERN , 2019, Autoimmunity reviews.

[20]  M. Cutolo,et al.  A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement , 2018, Respiratory Research.

[21]  M. Cutolo,et al.  The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis. , 2018, Microvascular Research.

[22]  E. Miyazaki,et al.  Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis , 2018, Clinical Rheumatology.

[23]  Y. Yılmaz,et al.  Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis , 2018, Angiology.

[24]  Maurizio Cutolo,et al.  Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis , 2018, Microcirculation.

[25]  U. Müller-Ladner,et al.  Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. , 2018, Autoimmunity reviews.

[26]  E. Chen,et al.  The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment , 2017, Chest.

[27]  G. Nickenig,et al.  Impaired Vascular Function in Sarcoidosis Patients. , 2017, Advances in experimental medicine and biology.

[28]  F. Cinetto,et al.  Rituximab in refractory sarcoidosis: a single centre experience , 2015, Clinical and Molecular Allergy.

[29]  R. Yachoui,et al.  Bone and bone marrow involvement in sarcoidosis , 2015, Rheumatology International.

[30]  D. Pastuszak-Lewandoska,et al.  TGF-β and SMADs mRNA Expression in Pulmonary Sarcoidosis. , 2015, Advances in experimental medicine and biology.

[31]  P. Górski,et al.  Expression of HIF-1A/VEGF/ING-4 Axis in Pulmonary Sarcoidosis. , 2015, Advances in experimental medicine and biology.

[32]  A. Karaarslan,et al.  The Prevalence of Antinuclear Antibodies in Patients with Sarcoidosis , 2014, Autoimmune diseases.

[33]  A. Prasse,et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[34]  Serena Guiducci,et al.  International consensus criteria for the diagnosis of Raynaud's phenomenon. , 2014, Journal of autoimmunity.

[35]  M. Aydoğan,et al.  HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests , 2013, Multidisciplinary Respiratory Medicine.

[36]  A. Nicholson,et al.  Pulmonary hypertension in sarcoidosis: A review , 2011, Respirology.

[37]  S. Cichon,et al.  VEGF gene haplotypes are associated with sarcoidosis. , 2010, Chest.

[38]  T. Takemura,et al.  Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies , 2005, Virchows Archiv A.

[39]  F. Sanguedolce,et al.  [Sarcoidosis presenting with Raynaud's syndrome: a case report]. , 2011, Reumatismo.

[40]  G. Hoffman,et al.  Sarcoidosis and systemic vasculitis. , 2000, Seminars in arthritis and rheumatism.

[41]  I. Gotsman,et al.  Anti-dsDNA antibodies in sarcoidosis. , 2000, Seminars in arthritis and rheumatism.

[42]  K. Müller,et al.  Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis , 1998, Virchows Archiv.

[43]  D. Boulware,et al.  Sarcoidosis presenting as antinuclear antibody positive glomerulonephritis. , 1988, Annals of the Rheumatic Diseases.

[44]  R. Crystal,et al.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. , 1981, The Journal of clinical investigation.

[45]  J. Scadding.  Prognosis of Intrathoracic Sarcoidosis in England , 1961, British medical journal.